

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | urate metabolic process (GO:0046415) | 8.60542977 |
| 2 | drug transmembrane transport (GO:0006855) | 8.23462421 |
| 3 | organic cation transport (GO:0015695) | 7.00946054 |
| 4 | drug transport (GO:0015893) | 6.96931864 |
| 5 | lysine catabolic process (GO:0006554) | 6.83815256 |
| 6 | lysine metabolic process (GO:0006553) | 6.83815256 |
| 7 | lymph vessel development (GO:0001945) | 6.75022317 |
| 8 | aminoglycoside antibiotic metabolic process (GO:0030647) | 6.38571376 |
| 9 | phosphate ion transport (GO:0006817) | 5.81555394 |
| 10 | quaternary ammonium group transport (GO:0015697) | 5.79640544 |
| 11 | metanephric tubule development (GO:0072170) | 5.73301520 |
| 12 | metanephric nephron tubule development (GO:0072234) | 5.73301520 |
| 13 | metanephric nephron epithelium development (GO:0072243) | 5.50924833 |
| 14 | surfactant homeostasis (GO:0043129) | 5.27562820 |
| 15 | metanephric epithelium development (GO:0072207) | 5.26905309 |
| 16 | excretion (GO:0007588) | 5.09117188 |
| 17 | response to mercury ion (GO:0046689) | 5.03411753 |
| 18 | renal absorption (GO:0070293) | 4.98516071 |
| 19 | phosphate ion transmembrane transport (GO:0035435) | 4.92843758 |
| 20 | cysteine metabolic process (GO:0006534) | 4.89660763 |
| 21 | endothelium development (GO:0003158) | 4.55844894 |
| 22 | glyoxylate metabolic process (GO:0046487) | 4.55384153 |
| 23 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 4.48717987 |
| 24 | nephron tubule development (GO:0072080) | 4.47902975 |
| 25 | short-chain fatty acid metabolic process (GO:0046459) | 4.44197065 |
| 26 | toxin transport (GO:1901998) | 4.41575742 |
| 27 | polyol transport (GO:0015791) | 4.40440645 |
| 28 | modified amino acid transport (GO:0072337) | 4.34816518 |
| 29 | indole-containing compound catabolic process (GO:0042436) | 4.32464424 |
| 30 | indolalkylamine catabolic process (GO:0046218) | 4.32464424 |
| 31 | tryptophan catabolic process (GO:0006569) | 4.32464424 |
| 32 | sodium-independent organic anion transport (GO:0043252) | 4.30908255 |
| 33 | chemical homeostasis within a tissue (GO:0048875) | 4.30603301 |
| 34 | behavioral response to nicotine (GO:0035095) | 4.26753553 |
| 35 | nephron epithelium development (GO:0072009) | 4.18789046 |
| 36 | L-ascorbic acid metabolic process (GO:0019852) | 4.13675167 |
| 37 | vascular endothelial growth factor signaling pathway (GO:0038084) | 4.08614330 |
| 38 | aspartate family amino acid catabolic process (GO:0009068) | 4.06835792 |
| 39 | tryptophan metabolic process (GO:0006568) | 4.01650906 |
| 40 | homocysteine metabolic process (GO:0050667) | 4.00428561 |
| 41 | vitamin transmembrane transport (GO:0035461) | 3.99817794 |
| 42 | renal tubule development (GO:0061326) | 3.89994400 |
| 43 | valine metabolic process (GO:0006573) | 3.89158264 |
| 44 | carnitine transport (GO:0015879) | 3.83334079 |
| 45 | amino-acid betaine transport (GO:0015838) | 3.83334079 |
| 46 | proline metabolic process (GO:0006560) | 3.81371929 |
| 47 | protein K11-linked deubiquitination (GO:0035871) | 3.78645862 |
| 48 | aromatic amino acid family catabolic process (GO:0009074) | 3.78082238 |
| 49 | response to phenylpropanoid (GO:0080184) | 3.75900140 |
| 50 | 2-oxoglutarate metabolic process (GO:0006103) | 3.71841834 |
| 51 | drug catabolic process (GO:0042737) | 3.69959788 |
| 52 | vitamin D metabolic process (GO:0042359) | 3.68857190 |
| 53 | vitamin transport (GO:0051180) | 3.66628049 |
| 54 | regulation of hippo signaling (GO:0035330) | 3.62263346 |
| 55 | nonribosomal peptide biosynthetic process (GO:0019184) | 3.61621594 |
| 56 | Notch signaling involved in heart development (GO:0061314) | 3.60745678 |
| 57 | tricarboxylic acid metabolic process (GO:0072350) | 3.49832699 |
| 58 | glutamate metabolic process (GO:0006536) | 3.48142691 |
| 59 | branched-chain amino acid metabolic process (GO:0009081) | 3.46920606 |
| 60 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.41389304 |
| 61 | kynurenine metabolic process (GO:0070189) | 3.38622613 |
| 62 | amino-acid betaine metabolic process (GO:0006577) | 3.35021255 |
| 63 | exogenous drug catabolic process (GO:0042738) | 3.34468601 |
| 64 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.33105210 |
| 65 | fucose catabolic process (GO:0019317) | 3.27883900 |
| 66 | L-fucose metabolic process (GO:0042354) | 3.27883900 |
| 67 | L-fucose catabolic process (GO:0042355) | 3.27883900 |
| 68 | sulfur compound transport (GO:0072348) | 3.20184968 |
| 69 | carnitine metabolic process (GO:0009437) | 3.15250866 |
| 70 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.08214920 |
| 71 | fatty acid beta-oxidation (GO:0006635) | 3.07713955 |
| 72 | phosphate ion homeostasis (GO:0055062) | 3.07705167 |
| 73 | trivalent inorganic anion homeostasis (GO:0072506) | 3.07705167 |
| 74 | cellular biogenic amine catabolic process (GO:0042402) | 3.07587288 |
| 75 | amine catabolic process (GO:0009310) | 3.07587288 |
| 76 | acetyl-CoA metabolic process (GO:0006084) | 3.06568234 |
| 77 | glutathione biosynthetic process (GO:0006750) | 3.04289008 |
| 78 | nephron tubule morphogenesis (GO:0072078) | 3.03873244 |
| 79 | nephron epithelium morphogenesis (GO:0072088) | 3.03873244 |
| 80 | kidney mesenchyme development (GO:0072074) | 3.02829283 |
| 81 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.99139298 |
| 82 | renal tubule morphogenesis (GO:0061333) | 2.98330673 |
| 83 | negative regulation of mesenchymal cell apoptotic process (GO:2001054) | 2.97564043 |
| 84 | mesenchymal-epithelial cell signaling (GO:0060638) | 2.95729492 |
| 85 | fatty acid oxidation (GO:0019395) | 2.89395152 |
| 86 | oligosaccharide catabolic process (GO:0009313) | 2.89191865 |
| 87 | serine family amino acid catabolic process (GO:0009071) | 2.87474755 |
| 88 | endothelial cell morphogenesis (GO:0001886) | 2.87366768 |
| 89 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.87340187 |
| 90 | hyperosmotic salinity response (GO:0042538) | 2.87288797 |
| 91 | cornea development in camera-type eye (GO:0061303) | 2.86127196 |
| 92 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.86114835 |
| 93 | pericardium development (GO:0060039) | 2.85358418 |
| 94 | response to pheromone (GO:0019236) | 2.85141545 |
| 95 | indolalkylamine metabolic process (GO:0006586) | 2.85137815 |
| 96 | cellular modified amino acid catabolic process (GO:0042219) | 2.85056347 |
| 97 | peptide catabolic process (GO:0043171) | 2.83860809 |
| 98 | flavonoid metabolic process (GO:0009812) | 2.83658319 |
| 99 | lipid oxidation (GO:0034440) | 2.83534820 |
| 100 | L-phenylalanine catabolic process (GO:0006559) | 2.80306760 |
| 101 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.80306760 |
| 102 | cilium morphogenesis (GO:0060271) | 2.80155825 |
| 103 | L-phenylalanine metabolic process (GO:0006558) | 2.79337731 |
| 104 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.79337731 |
| 105 | doxorubicin metabolic process (GO:0044598) | 2.78853376 |
| 106 | daunorubicin metabolic process (GO:0044597) | 2.78853376 |
| 107 | polyketide metabolic process (GO:0030638) | 2.78853376 |
| 108 | sulfation (GO:0051923) | 2.78754470 |
| 109 | estrogen biosynthetic process (GO:0006703) | 2.77259691 |
| 110 | response to growth hormone (GO:0060416) | 2.76471795 |
| 111 | transepithelial transport (GO:0070633) | 2.75857481 |
| 112 | kidney morphogenesis (GO:0060993) | 2.75078886 |
| 113 | regulation of steroid hormone biosynthetic process (GO:0090030) | 2.74940995 |
| 114 | retinal metabolic process (GO:0042574) | 2.74579021 |
| 115 | transcytosis (GO:0045056) | 2.74263823 |
| 116 | nephron tubule formation (GO:0072079) | 2.74244324 |
| 117 | glomerular filtration (GO:0003094) | 2.73321528 |
| 118 | protein-cofactor linkage (GO:0018065) | 2.73148789 |
| 119 | indole-containing compound metabolic process (GO:0042430) | 2.73035725 |
| 120 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.72934945 |
| 121 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.72450211 |
| 122 | nonmotile primary cilium assembly (GO:0035058) | 2.72202366 |
| 123 | cellular ketone body metabolic process (GO:0046950) | 2.71655603 |
| 124 | serine family amino acid metabolic process (GO:0009069) | 2.70341026 |
| 125 | thyroid hormone metabolic process (GO:0042403) | 2.70215450 |
| 126 | histamine transport (GO:0051608) | 2.69531747 |
| 127 | cellular glucuronidation (GO:0052695) | 2.68285847 |
| 128 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 2.65565992 |
| 129 | ketone body metabolic process (GO:1902224) | 2.63984414 |
| 130 | protein localization to cilium (GO:0061512) | 2.63396425 |
| 131 | oxidative demethylation (GO:0070989) | 2.61110112 |
| 132 | glucuronate metabolic process (GO:0019585) | 2.60974587 |
| 133 | uronic acid metabolic process (GO:0006063) | 2.60974587 |
| 134 | negative regulation of axon guidance (GO:1902668) | 2.59966214 |
| 135 | gamma-aminobutyric acid transport (GO:0015812) | 2.57437459 |
| 136 | arginine metabolic process (GO:0006525) | 2.57230426 |
| 137 | platelet dense granule organization (GO:0060155) | 2.54311447 |
| 138 | coenzyme catabolic process (GO:0009109) | 2.53945069 |
| 139 | detection of light stimulus involved in visual perception (GO:0050908) | 2.51145831 |
| 140 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.51145831 |
| 141 | nucleotide transmembrane transport (GO:1901679) | 2.51025607 |
| 142 | epithelial cilium movement (GO:0003351) | 2.50148037 |
| 143 | positive regulation of fatty acid transport (GO:2000193) | 2.48960913 |
| 144 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.48373307 |
| 145 | dopamine transport (GO:0015872) | 2.45101727 |
| 146 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.44816368 |
| 147 | keratinocyte development (GO:0003334) | 2.44797472 |
| 148 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.44715852 |
| 149 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.44715852 |
| 150 | detection of mechanical stimulus involved in sensory perception (GO:0050974) | 2.42603409 |
| 151 | negative regulation of mast cell activation (GO:0033004) | 2.41768839 |
| 152 | inner ear receptor stereocilium organization (GO:0060122) | 2.41289456 |
| 153 | positive regulation of icosanoid secretion (GO:0032305) | 2.40786398 |
| 154 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.39561790 |
| 155 | photoreceptor cell maintenance (GO:0045494) | 2.38704277 |
| 156 | reflex (GO:0060004) | 2.38674270 |
| 157 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 2.38010967 |
| 158 | glomerular basement membrane development (GO:0032836) | 2.37127055 |
| 159 | arginine catabolic process (GO:0006527) | 2.36691055 |
| 160 | S-adenosylmethionine metabolic process (GO:0046500) | 2.34554726 |
| 161 | drug metabolic process (GO:0017144) | 2.34292250 |
| 162 | positive regulation of insulin-like growth factor receptor signaling pathway (GO:0043568) | 2.31513361 |
| 163 | somite development (GO:0061053) | 2.30679213 |
| 164 | cilium organization (GO:0044782) | 2.29676677 |
| 165 | intraciliary transport (GO:0042073) | 2.28357150 |
| 166 | diterpenoid biosynthetic process (GO:0016102) | 2.27765152 |
| 167 | cilium assembly (GO:0042384) | 2.27236396 |
| 168 | response to redox state (GO:0051775) | 2.26378210 |
| 169 | regulation of protein glycosylation (GO:0060049) | 2.26142448 |
| 170 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 2.25974034 |
| 171 | estrogen metabolic process (GO:0008210) | 2.25812645 |
| 172 | quinone metabolic process (GO:1901661) | 2.24135529 |
| 173 | cellular response to vitamin D (GO:0071305) | 2.23722239 |
| 174 | neural tube formation (GO:0001841) | 2.22040994 |
| 175 | thyroid hormone generation (GO:0006590) | 2.21427274 |
| 176 | phenylpropanoid metabolic process (GO:0009698) | 2.21163882 |
| 177 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.20974598 |
| 178 | regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095) | 2.20877812 |
| 179 | head development (GO:0060322) | 2.19880631 |
| 180 | regulation of hexokinase activity (GO:1903299) | 2.19400817 |
| 181 | regulation of glucokinase activity (GO:0033131) | 2.19400817 |
| 182 | nucleobase catabolic process (GO:0046113) | 2.19259667 |
| 183 | positive regulation of fatty acid oxidation (GO:0046321) | 2.18881065 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.96922738 |
| 2 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.84703113 |
| 3 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.82657581 |
| 4 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 2.79886526 |
| 5 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.66980050 |
| 6 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.63232747 |
| 7 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.43970112 |
| 8 | VDR_22108803_ChIP-Seq_LS180_Human | 2.43919754 |
| 9 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.39425537 |
| 10 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 2.31138065 |
| 11 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 2.13558678 |
| 12 | * GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.13228751 |
| 13 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 2.10074335 |
| 14 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.01878081 |
| 15 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.00958111 |
| 16 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.99046568 |
| 17 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.95050826 |
| 18 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.91768933 |
| 19 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.86121720 |
| 20 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.84259935 |
| 21 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.81019215 |
| 22 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.74581110 |
| 23 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.74087733 |
| 24 | EWS_26573619_Chip-Seq_HEK293_Human | 1.73410815 |
| 25 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.71787982 |
| 26 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.68063581 |
| 27 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.67710303 |
| 28 | TP53_16413492_ChIP-PET_HCT116_Human | 1.67246665 |
| 29 | CJUN_26792858_Chip-Seq_BT549_Human | 1.66688605 |
| 30 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.66665894 |
| 31 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.66665894 |
| 32 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.66345663 |
| 33 | STAT3_23295773_ChIP-Seq_U87_Human | 1.66323509 |
| 34 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.65084248 |
| 35 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.64793547 |
| 36 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.63933100 |
| 37 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.63147353 |
| 38 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.62371851 |
| 39 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.59935125 |
| 40 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.59430013 |
| 41 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.57962845 |
| 42 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.57070766 |
| 43 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.54374909 |
| 44 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.52778593 |
| 45 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.51714484 |
| 46 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.51385862 |
| 47 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.51385862 |
| 48 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.49620116 |
| 49 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.48733296 |
| 50 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.48677056 |
| 51 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.48346901 |
| 52 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.47842927 |
| 53 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.47103515 |
| 54 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.46505298 |
| 55 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.45811364 |
| 56 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.45167379 |
| 57 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.44549348 |
| 58 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.43791801 |
| 59 | TCF4_23295773_ChIP-Seq_U87_Human | 1.43656183 |
| 60 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.43274177 |
| 61 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.42524925 |
| 62 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.42524925 |
| 63 | P300_19829295_ChIP-Seq_ESCs_Human | 1.41849987 |
| 64 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.41098077 |
| 65 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.40907739 |
| 66 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.40644116 |
| 67 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.40634972 |
| 68 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.40613264 |
| 69 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.40562212 |
| 70 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.39191583 |
| 71 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.38327807 |
| 72 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.38250859 |
| 73 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.37337503 |
| 74 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.35483666 |
| 75 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.35256826 |
| 76 | RXR_22108803_ChIP-Seq_LS180_Human | 1.35069447 |
| 77 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.35064507 |
| 78 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.34560635 |
| 79 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.34218732 |
| 80 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.33933659 |
| 81 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.33192509 |
| 82 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.31096724 |
| 83 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.30323950 |
| 84 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.29170901 |
| 85 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.28578842 |
| 86 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.28506255 |
| 87 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.28246291 |
| 88 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.27686943 |
| 89 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.27652481 |
| 90 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.27639140 |
| 91 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.27460312 |
| 92 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.27118365 |
| 93 | * MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.27082369 |
| 94 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.26658396 |
| 95 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.26638188 |
| 96 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.26081236 |
| 97 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.23959684 |
| 98 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.22869465 |
| 99 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.21332464 |
| 100 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.21085739 |
| 101 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.20383577 |
| 102 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.20029823 |
| 103 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.19992545 |
| 104 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.19944167 |
| 105 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.19657673 |
| 106 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.19639538 |
| 107 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.19077029 |
| 108 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.17783442 |
| 109 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.16822620 |
| 110 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.16315294 |
| 111 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.15848760 |
| 112 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.14844703 |
| 113 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.14844703 |
| 114 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.14038241 |
| 115 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.13567377 |
| 116 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.13481974 |
| 117 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.12495083 |
| 118 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.12461541 |
| 119 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.11808580 |
| 120 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.11642983 |
| 121 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.10772715 |
| 122 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.10481461 |
| 123 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.08467984 |
| 124 | FUS_26573619_Chip-Seq_HEK293_Human | 1.07963994 |
| 125 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.04630636 |
| 126 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.03919257 |
| 127 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.03469425 |
| 128 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.02632305 |
| 129 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.02030558 |
| 130 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.01817385 |
| 131 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.01617286 |
| 132 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.01311221 |
| 133 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.01091962 |
| 134 | TBL1_22424771_ChIP-Seq_293T_Human | 1.00932531 |
| 135 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.00769934 |
| 136 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.00625745 |
| 137 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.00523194 |
| 138 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.00471830 |
| 139 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.99864896 |
| 140 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.99864896 |
| 141 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.99661861 |
| 142 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.99585306 |
| 143 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.99262643 |
| 144 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 0.99149078 |
| 145 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.98938767 |
| 146 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.98880279 |
| 147 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 0.97973249 |
| 148 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.97507547 |
| 149 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.97302239 |
| 150 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.96596243 |
| 151 | AR_25329375_ChIP-Seq_VCAP_Human | 0.96296683 |
| 152 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.96099939 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 6.43241249 |
| 2 | MP0004043_abnormal_pH_regulation | 4.78199444 |
| 3 | MP0005332_abnormal_amino_acid | 3.69971259 |
| 4 | MP0003195_calcinosis | 3.54439393 |
| 5 | MP0004272_abnormal_basement_membrane | 3.45331282 |
| 6 | MP0004019_abnormal_vitamin_homeostasis | 3.41635204 |
| 7 | MP0001879_abnormal_lymphatic_vessel | 3.40402959 |
| 8 | MP0002138_abnormal_hepatobiliary_system | 3.03843056 |
| 9 | MP0005377_hearing/vestibular/ear_phenot | 2.95147735 |
| 10 | MP0003878_abnormal_ear_physiology | 2.95147735 |
| 11 | MP0010386_abnormal_urinary_bladder | 2.88486112 |
| 12 | MP0001958_emphysema | 2.87846859 |
| 13 | MP0009643_abnormal_urine_homeostasis | 2.84979039 |
| 14 | MP0002139_abnormal_hepatobiliary_system | 2.62580812 |
| 15 | MP0005167_abnormal_blood-brain_barrier | 2.50142259 |
| 16 | MP0001765_abnormal_ion_homeostasis | 2.48295803 |
| 17 | MP0001756_abnormal_urination | 2.42806341 |
| 18 | MP0002136_abnormal_kidney_physiology | 2.33822922 |
| 19 | MP0006054_spinal_hemorrhage | 2.28284461 |
| 20 | MP0005084_abnormal_gallbladder_morpholo | 2.27759271 |
| 21 | MP0004147_increased_porphyrin_level | 2.24758196 |
| 22 | MP0003950_abnormal_plasma_membrane | 2.14696467 |
| 23 | MP0005636_abnormal_mineral_homeostasis | 1.97623600 |
| 24 | MP0003252_abnormal_bile_duct | 1.92465259 |
| 25 | MP0003136_yellow_coat_color | 1.92121843 |
| 26 | MP0000372_irregular_coat_pigmentation | 1.90518567 |
| 27 | MP0000427_abnormal_hair_cycle | 1.88329553 |
| 28 | MP0005551_abnormal_eye_electrophysiolog | 1.84381588 |
| 29 | MP0005174_abnormal_tail_pigmentation | 1.71086094 |
| 30 | MP0002089_abnormal_postnatal_growth/wei | 1.70719431 |
| 31 | MP0002896_abnormal_bone_mineralization | 1.68566448 |
| 32 | MP0008875_abnormal_xenobiotic_pharmacok | 1.66370182 |
| 33 | MP0001986_abnormal_taste_sensitivity | 1.60191766 |
| 34 | MP0002837_dystrophic_cardiac_calcinosis | 1.55998864 |
| 35 | MP0006072_abnormal_retinal_apoptosis | 1.50047347 |
| 36 | MP0003279_aneurysm | 1.47807702 |
| 37 | MP0010368_abnormal_lymphatic_system | 1.46997670 |
| 38 | MP0004484_altered_response_of | 1.44992050 |
| 39 | MP0009780_abnormal_chondrocyte_physiolo | 1.44971958 |
| 40 | MP0002282_abnormal_trachea_morphology | 1.44640380 |
| 41 | MP0004142_abnormal_muscle_tone | 1.44133335 |
| 42 | MP0005253_abnormal_eye_physiology | 1.40409886 |
| 43 | MP0009384_cardiac_valve_regurgitation | 1.39884878 |
| 44 | MP0005171_absent_coat_pigmentation | 1.38752654 |
| 45 | MP0005275_abnormal_skin_tensile | 1.36580110 |
| 46 | MP0005623_abnormal_meninges_morphology | 1.34682911 |
| 47 | MP0002928_abnormal_bile_duct | 1.34283913 |
| 48 | MP0005408_hypopigmentation | 1.33490109 |
| 49 | MP0002249_abnormal_larynx_morphology | 1.32686789 |
| 50 | MP0005503_abnormal_tendon_morphology | 1.32534433 |
| 51 | MP0000538_abnormal_urinary_bladder | 1.31891971 |
| 52 | MP0002234_abnormal_pharynx_morphology | 1.29876864 |
| 53 | MP0008961_abnormal_basal_metabolism | 1.29769763 |
| 54 | MP0004133_heterotaxia | 1.29572385 |
| 55 | MP0001485_abnormal_pinna_reflex | 1.28826295 |
| 56 | MP0000163_abnormal_cartilage_morphology | 1.28067811 |
| 57 | MP0009379_abnormal_foot_pigmentation | 1.27684874 |
| 58 | MP0005257_abnormal_intraocular_pressure | 1.26467075 |
| 59 | MP0003011_delayed_dark_adaptation | 1.26156433 |
| 60 | MP0003937_abnormal_limbs/digits/tail_de | 1.25963840 |
| 61 | MP0002108_abnormal_muscle_morphology | 1.22872876 |
| 62 | MP0005085_abnormal_gallbladder_physiolo | 1.22570412 |
| 63 | MP0004885_abnormal_endolymph | 1.21301296 |
| 64 | MP0002168_other_aberrant_phenotype | 1.19068905 |
| 65 | MP0002653_abnormal_ependyma_morphology | 1.18952978 |
| 66 | MP0003646_muscle_fatigue | 1.17227236 |
| 67 | MP0003300_gastrointestinal_ulcer | 1.16756999 |
| 68 | MP0005365_abnormal_bile_salt | 1.16233667 |
| 69 | MP0002009_preneoplasia | 1.15970186 |
| 70 | MP0000762_abnormal_tongue_morphology | 1.15409827 |
| 71 | MP0006276_abnormal_autonomic_nervous | 1.15192576 |
| 72 | MP0000383_abnormal_hair_follicle | 1.14153681 |
| 73 | MP0009250_abnormal_appendicular_skeleto | 1.13989281 |
| 74 | MP0000230_abnormal_systemic_arterial | 1.12380874 |
| 75 | MP0002115_abnormal_skeleton_extremities | 1.09533587 |
| 76 | MP0005195_abnormal_posterior_eye | 1.04033587 |
| 77 | MP0001324_abnormal_eye_pigmentation | 1.03275289 |
| 78 | MP0003283_abnormal_digestive_organ | 1.02244284 |
| 79 | MP0003755_abnormal_palate_morphology | 1.02049345 |
| 80 | MP0002938_white_spotting | 1.00861775 |
| 81 | MP0008789_abnormal_olfactory_epithelium | 1.00754116 |
| 82 | MP0001968_abnormal_touch/_nociception | 0.98729601 |
| 83 | MP0005197_abnormal_uvea_morphology | 0.98630423 |
| 84 | MP0001270_distended_abdomen | 0.97809162 |
| 85 | MP0006292_abnormal_olfactory_placode | 0.96930325 |
| 86 | MP0005165_increased_susceptibility_to | 0.96896863 |
| 87 | MP0003186_abnormal_redox_activity | 0.95832080 |
| 88 | MP0001501_abnormal_sleep_pattern | 0.95473360 |
| 89 | MP0000371_diluted_coat_color | 0.95011110 |
| 90 | MP0010234_abnormal_vibrissa_follicle | 0.94948803 |
| 91 | MP0001177_atelectasis | 0.94372304 |
| 92 | MP0005389_reproductive_system_phenotype | 0.93424698 |
| 93 | MP0002233_abnormal_nose_morphology | 0.92445247 |
| 94 | MP0010329_abnormal_lipoprotein_level | 0.90128214 |
| 95 | MP0002102_abnormal_ear_morphology | 0.89796207 |
| 96 | MP0002095_abnormal_skin_pigmentation | 0.89727735 |
| 97 | MP0002638_abnormal_pupillary_reflex | 0.89163815 |
| 98 | MP0008872_abnormal_physiological_respon | 0.88946303 |
| 99 | MP0002098_abnormal_vibrissa_morphology | 0.88001027 |
| 100 | MP0005595_abnormal_vascular_smooth | 0.87853083 |
| 101 | MP0001666_abnormal_nutrient_absorption | 0.87443012 |
| 102 | MP0004134_abnormal_chest_morphology | 0.87239292 |
| 103 | MP0003638_abnormal_response/metabolism_ | 0.85204314 |
| 104 | MP0002135_abnormal_kidney_morphology | 0.85051261 |
| 105 | MP0001299_abnormal_eye_distance/ | 0.84998825 |
| 106 | MP0000639_abnormal_adrenal_gland | 0.84553169 |
| 107 | MP0009278_abnormal_bone_marrow | 0.84527336 |
| 108 | MP0000647_abnormal_sebaceous_gland | 0.84486056 |
| 109 | MP0000026_abnormal_inner_ear | 0.83792136 |
| 110 | MP0008438_abnormal_cutaneous_collagen | 0.83500135 |
| 111 | MP0005409_darkened_coat_color | 0.83455708 |
| 112 | MP0000534_abnormal_ureter_morphology | 0.82607909 |
| 113 | MP0003943_abnormal_hepatobiliary_system | 0.82564205 |
| 114 | MP0001905_abnormal_dopamine_level | 0.82521986 |
| 115 | MP0000569_abnormal_digit_pigmentation | 0.81907470 |
| 116 | MP0002557_abnormal_social/conspecific_i | 0.81883187 |
| 117 | MP0002113_abnormal_skeleton_development | 0.81437687 |
| 118 | MP0002295_abnormal_pulmonary_circulatio | 0.79540179 |
| 119 | MP0005386_behavior/neurological_phenoty | 0.79394275 |
| 120 | MP0004924_abnormal_behavior | 0.79394275 |
| 121 | MP0000778_abnormal_nervous_system | 0.79315790 |
| 122 | MP0002160_abnormal_reproductive_system | 0.78565992 |
| 123 | MP0004085_abnormal_heartbeat | 0.77311896 |
| 124 | MP0000015_abnormal_ear_pigmentation | 0.77294393 |
| 125 | MP0000049_abnormal_middle_ear | 0.76917636 |
| 126 | MP0002075_abnormal_coat/hair_pigmentati | 0.76851498 |
| 127 | MP0005395_other_phenotype | 0.75590624 |
| 128 | MP0003936_abnormal_reproductive_system | 0.75505125 |
| 129 | MP0010678_abnormal_skin_adnexa | 0.75322955 |
| 130 | MP0002109_abnormal_limb_morphology | 0.75128197 |
| 131 | MP0003941_abnormal_skin_development | 0.74922182 |
| 132 | MP0002876_abnormal_thyroid_physiology | 0.72371666 |
| 133 | MP0005330_cardiomyopathy | 0.70421103 |
| 134 | MP0003795_abnormal_bone_structure | 0.70401726 |
| 135 | MP0001188_hyperpigmentation | 0.70043307 |
| 136 | MP0008775_abnormal_heart_ventricle | 0.68273412 |
| 137 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.67604041 |
| 138 | MP0005670_abnormal_white_adipose | 0.62236458 |
| 139 | MP0002998_abnormal_bone_remodeling | 0.61382183 |
| 140 | MP0003942_abnormal_urinary_system | 0.60862408 |
| 141 | MP0009697_abnormal_copulation | 0.60512385 |
| 142 | MP0005508_abnormal_skeleton_morphology | 0.59940638 |
| 143 | MP0002933_joint_inflammation | 0.58904531 |
| 144 | MP0001915_intracranial_hemorrhage | 0.58774729 |
| 145 | MP0000432_abnormal_head_morphology | 0.58056671 |
| 146 | MP0003935_abnormal_craniofacial_develop | 0.57220165 |
| 147 | MP0005388_respiratory_system_phenotype | 0.56955685 |
| 148 | MP0002133_abnormal_respiratory_system | 0.56955685 |
| 149 | MP0003091_abnormal_cell_migration | 0.56521241 |
| 150 | MP0006138_congestive_heart_failure | 0.56343097 |
| 151 | MP0000767_abnormal_smooth_muscle | 0.55870174 |
| 152 | MP0005319_abnormal_enzyme/_coenzyme | 0.55852287 |
| 153 | MP0000377_abnormal_hair_follicle | 0.55617910 |
| 154 | MP0001784_abnormal_fluid_regulation | 0.55343434 |
| 155 | MP0002127_abnormal_cardiovascular_syste | 0.54724762 |
| 156 | MP0009764_decreased_sensitivity_to | 0.54688913 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Metabolic alkalosis (HP:0200114) | 7.06616146 |
| 2 | Increased circulating renin level (HP:0000848) | 6.84267704 |
| 3 | Hypomagnesemia (HP:0002917) | 6.67112417 |
| 4 | Hypokalemic alkalosis (HP:0001949) | 6.50143068 |
| 5 | Polyuria (HP:0000103) | 6.22856721 |
| 6 | Abnormal urine output (HP:0012590) | 5.86179734 |
| 7 | Hyperactive renin-angiotensin system (HP:0000841) | 5.81770880 |
| 8 | Abnormality of chloride homeostasis (HP:0011422) | 5.45845047 |
| 9 | Polydipsia (HP:0001959) | 5.42772552 |
| 10 | Abnormal drinking behavior (HP:0030082) | 5.42772552 |
| 11 | Abnormality of magnesium homeostasis (HP:0004921) | 5.35447910 |
| 12 | Abnormality of renal excretion (HP:0011036) | 5.32916738 |
| 13 | Gout (HP:0001997) | 5.20949935 |
| 14 | Tetany (HP:0001281) | 5.00308416 |
| 15 | Hyperuricemia (HP:0002149) | 4.81005233 |
| 16 | Increased purine levels (HP:0004368) | 4.81005233 |
| 17 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.58833383 |
| 18 | Proximal tubulopathy (HP:0000114) | 4.38247141 |
| 19 | Pancreatic cysts (HP:0001737) | 4.05643252 |
| 20 | Hyperaldosteronism (HP:0000859) | 4.03809724 |
| 21 | Renal salt wasting (HP:0000127) | 4.03356253 |
| 22 | Abnormality of renin-angiotensin system (HP:0000847) | 3.96471730 |
| 23 | Delayed epiphyseal ossification (HP:0002663) | 3.87450490 |
| 24 | Pancreatic fibrosis (HP:0100732) | 3.83396557 |
| 25 | Alkalosis (HP:0001948) | 3.80593854 |
| 26 | Molar tooth sign on MRI (HP:0002419) | 3.75707372 |
| 27 | Abnormality of midbrain morphology (HP:0002418) | 3.75707372 |
| 28 | Abnormality of purine metabolism (HP:0004352) | 3.70393029 |
| 29 | Renal tubular acidosis (HP:0001947) | 3.55814656 |
| 30 | Epiphyseal dysplasia (HP:0002656) | 3.55440335 |
| 31 | Hyperglycinuria (HP:0003108) | 3.48632700 |
| 32 | True hermaphroditism (HP:0010459) | 3.46325091 |
| 33 | Abnormality of proline metabolism (HP:0010907) | 3.42809935 |
| 34 | Hydroxyprolinuria (HP:0003080) | 3.42809935 |
| 35 | Chorioretinal atrophy (HP:0000533) | 3.39935635 |
| 36 | Congenital stationary night blindness (HP:0007642) | 3.38929101 |
| 37 | Type II lissencephaly (HP:0007260) | 3.34219378 |
| 38 | Chronic hepatic failure (HP:0100626) | 3.27427971 |
| 39 | Hypercalciuria (HP:0002150) | 3.23019360 |
| 40 | Nephronophthisis (HP:0000090) | 3.17443301 |
| 41 | Confusion (HP:0001289) | 3.14000117 |
| 42 | Hypokalemia (HP:0002900) | 3.06350562 |
| 43 | Tubular atrophy (HP:0000092) | 2.97809626 |
| 44 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.96263273 |
| 45 | Abnormality of glycine metabolism (HP:0010895) | 2.96263273 |
| 46 | Abnormal tarsal ossification (HP:0008369) | 2.95989338 |
| 47 | Ketoacidosis (HP:0001993) | 2.94779101 |
| 48 | Keratoconus (HP:0000563) | 2.90810075 |
| 49 | Increased corneal curvature (HP:0100692) | 2.90810075 |
| 50 | Cerebellar dysplasia (HP:0007033) | 2.86684640 |
| 51 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.82924104 |
| 52 | Attenuation of retinal blood vessels (HP:0007843) | 2.79611535 |
| 53 | Delayed CNS myelination (HP:0002188) | 2.71168767 |
| 54 | Cystic liver disease (HP:0006706) | 2.70765861 |
| 55 | Hyperventilation (HP:0002883) | 2.68974613 |
| 56 | Neonatal short-limb short stature (HP:0008921) | 2.67787484 |
| 57 | Vitreoretinal degeneration (HP:0000655) | 2.62716760 |
| 58 | Congenital sensorineural hearing impairment (HP:0008527) | 2.60485740 |
| 59 | Abnormality of potassium homeostasis (HP:0011042) | 2.58596985 |
| 60 | Medial flaring of the eyebrow (HP:0010747) | 2.58310948 |
| 61 | Metaphyseal cupping (HP:0003021) | 2.57936608 |
| 62 | Enlarged kidneys (HP:0000105) | 2.48392116 |
| 63 | Occipital encephalocele (HP:0002085) | 2.44909945 |
| 64 | Abnormality of nucleobase metabolism (HP:0010932) | 2.44902567 |
| 65 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.43735049 |
| 66 | Generalized aminoaciduria (HP:0002909) | 2.40384240 |
| 67 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.40222072 |
| 68 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.33120017 |
| 69 | Lymphangioma (HP:0100764) | 2.28443811 |
| 70 | Nephrocalcinosis (HP:0000121) | 2.28163251 |
| 71 | Metaphyseal irregularity (HP:0003025) | 2.27592809 |
| 72 | Ketosis (HP:0001946) | 2.27450573 |
| 73 | Decreased circulating renin level (HP:0003351) | 2.24088553 |
| 74 | Abnormality of carpal bone ossification (HP:0006257) | 2.21261926 |
| 75 | Widely patent fontanelles and sutures (HP:0004492) | 2.16058363 |
| 76 | Hypoplastic ischia (HP:0003175) | 2.15390932 |
| 77 | Congenital hepatic fibrosis (HP:0002612) | 2.13321366 |
| 78 | Hip contracture (HP:0003273) | 2.13280713 |
| 79 | Renal cortical cysts (HP:0000803) | 2.12688985 |
| 80 | Abnormal foot bone ossification (HP:0010675) | 2.12544091 |
| 81 | Irregular epiphyses (HP:0010582) | 2.12246843 |
| 82 | Potter facies (HP:0002009) | 2.11398500 |
| 83 | Facial shape deformation (HP:0011334) | 2.11398500 |
| 84 | Glycosuria (HP:0003076) | 2.10715800 |
| 85 | Abnormality of urine glucose concentration (HP:0011016) | 2.10715800 |
| 86 | Bile duct proliferation (HP:0001408) | 2.07181460 |
| 87 | Abnormal biliary tract physiology (HP:0012439) | 2.07181460 |
| 88 | Hypoplasia of the iris (HP:0007676) | 2.06605200 |
| 89 | Stage 5 chronic kidney disease (HP:0003774) | 2.05002216 |
| 90 | Vascular calcification (HP:0004934) | 2.04387142 |
| 91 | Rickets (HP:0002748) | 2.03924392 |
| 92 | Flat acetabular roof (HP:0003180) | 2.03839168 |
| 93 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.01214474 |
| 94 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.99725667 |
| 95 | Tubulointerstitial fibrosis (HP:0005576) | 1.99458789 |
| 96 | Nephrolithiasis (HP:0000787) | 1.99101513 |
| 97 | Congenital primary aphakia (HP:0007707) | 1.98990678 |
| 98 | Nephrogenic diabetes insipidus (HP:0009806) | 1.98762354 |
| 99 | Gait imbalance (HP:0002141) | 1.98687721 |
| 100 | Chondrocalcinosis (HP:0000934) | 1.97789258 |
| 101 | Thyroid-stimulating hormone excess (HP:0002925) | 1.97076101 |
| 102 | Abnormality of the pons (HP:0007361) | 1.96998012 |
| 103 | Abolished electroretinogram (ERG) (HP:0000550) | 1.96951479 |
| 104 | Decreased central vision (HP:0007663) | 1.96496310 |
| 105 | Abnormality of the renal cortex (HP:0011035) | 1.96185150 |
| 106 | Cardiovascular calcification (HP:0011915) | 1.96074506 |
| 107 | Abnormality of Sharpey fibers (HP:0100685) | 1.93605798 |
| 108 | Abnormality of the nasal septum (HP:0000419) | 1.92867615 |
| 109 | Hypoplasia of the pons (HP:0012110) | 1.92200171 |
| 110 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.90428506 |
| 111 | Abnormal hand bone ossification (HP:0010660) | 1.90168369 |
| 112 | Abnormality of the ischium (HP:0003174) | 1.88902071 |
| 113 | Short tibia (HP:0005736) | 1.87970325 |
| 114 | Mesomelia (HP:0003027) | 1.87883809 |
| 115 | Furrowed tongue (HP:0000221) | 1.87420572 |
| 116 | Postaxial foot polydactyly (HP:0001830) | 1.86269240 |
| 117 | Limited hip movement (HP:0008800) | 1.86107078 |
| 118 | Hypothermia (HP:0002045) | 1.85964750 |
| 119 | Abnormal ossification of hand bones (HP:0005921) | 1.85689027 |
| 120 | Hyperphosphaturia (HP:0003109) | 1.85101675 |
| 121 | Abnormality of sodium homeostasis (HP:0010931) | 1.84108372 |
| 122 | Cupped ribs (HP:0000887) | 1.83740306 |
| 123 | Genital tract atresia (HP:0001827) | 1.83608143 |
| 124 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.82689898 |
| 125 | Choroideremia (HP:0001139) | 1.82351675 |
| 126 | Follicular hyperkeratosis (HP:0007502) | 1.82304432 |
| 127 | Dehydration (HP:0001944) | 1.81898271 |
| 128 | Abnormal urine phosphate concentration (HP:0012599) | 1.80701843 |
| 129 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.78551242 |
| 130 | Hypophosphatemia (HP:0002148) | 1.77593368 |
| 131 | Fair hair (HP:0002286) | 1.77024776 |
| 132 | Concave nail (HP:0001598) | 1.76115021 |
| 133 | Vaginal atresia (HP:0000148) | 1.75770608 |
| 134 | Hyperglycinemia (HP:0002154) | 1.75197300 |
| 135 | Protuberant abdomen (HP:0001538) | 1.74805582 |
| 136 | Pendular nystagmus (HP:0012043) | 1.74484053 |
| 137 | Lissencephaly (HP:0001339) | 1.74276899 |
| 138 | Sclerocornea (HP:0000647) | 1.73563281 |
| 139 | Renal tubular dysfunction (HP:0000124) | 1.73347413 |
| 140 | Abnormality of alanine metabolism (HP:0010916) | 1.73016895 |
| 141 | Hyperalaninemia (HP:0003348) | 1.73016895 |
| 142 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.73016895 |
| 143 | Bulbous nose (HP:0000414) | 1.72457425 |
| 144 | Tubulointerstitial abnormality (HP:0001969) | 1.72432335 |
| 145 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.71567844 |
| 146 | Abnormal vertebral ossification (HP:0100569) | 1.71321527 |
| 147 | Postaxial hand polydactyly (HP:0001162) | 1.70826270 |
| 148 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.70220778 |
| 149 | Hypoplasia of the uterus (HP:0000013) | 1.70003035 |
| 150 | Hypoplasia of the fovea (HP:0007750) | 1.68860820 |
| 151 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.68860820 |
| 152 | Metaphyseal dysplasia (HP:0100255) | 1.68041058 |
| 153 | Hypoplastic nipples (HP:0002557) | 1.67263273 |
| 154 | Vascular tortuosity (HP:0004948) | 1.67143734 |
| 155 | Enlarged epiphyses (HP:0010580) | 1.67084129 |
| 156 | Abnormal albumin level (HP:0012116) | 1.65239816 |
| 157 | Hypoalbuminemia (HP:0003073) | 1.65239816 |
| 158 | Hypoplastic labia majora (HP:0000059) | 1.64750754 |
| 159 | Albinism (HP:0001022) | 1.64133820 |
| 160 | Cervical subluxation (HP:0003308) | 1.64111587 |
| 161 | Increased number of teeth (HP:0011069) | 1.64064456 |
| 162 | Hyponatremia (HP:0002902) | 1.63884907 |
| 163 | Wide cranial sutures (HP:0010537) | 1.61677118 |
| 164 | Abnormality of the middle phalanges of the toes (HP:0010183) | 1.60178551 |
| 165 | Hypoglycemic coma (HP:0001325) | 1.58379143 |
| 166 | Abnormality of the renal medulla (HP:0100957) | 1.58107063 |
| 167 | Mild short stature (HP:0003502) | 1.57404721 |
| 168 | Abnormality of incisor morphology (HP:0011063) | 1.57263687 |
| 169 | Distal lower limb muscle weakness (HP:0009053) | 1.55487081 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | WNK3 | 8.10272915 |
| 2 | OXSR1 | 6.32190649 |
| 3 | WNK4 | 6.00509395 |
| 4 | KDR | 3.68233796 |
| 5 | STK39 | 3.26207758 |
| 6 | ADRBK2 | 2.85667295 |
| 7 | TIE1 | 2.59067622 |
| 8 | PDK2 | 2.14960128 |
| 9 | PINK1 | 1.97293423 |
| 10 | TGFBR2 | 1.89033257 |
| 11 | STK38L | 1.78204331 |
| 12 | PTK2B | 1.73021998 |
| 13 | MAP4K2 | 1.72506893 |
| 14 | TLK1 | 1.68061252 |
| 15 | WNK1 | 1.61980921 |
| 16 | INSRR | 1.61181667 |
| 17 | ADRBK1 | 1.51754096 |
| 18 | SGK494 | 1.49600499 |
| 19 | SGK223 | 1.49600499 |
| 20 | DDR2 | 1.45518820 |
| 21 | MAP3K12 | 1.37723188 |
| 22 | TAOK3 | 1.32692886 |
| 23 | AKT3 | 1.29809743 |
| 24 | ZAK | 1.28800788 |
| 25 | NUAK1 | 1.26727141 |
| 26 | MST4 | 1.26622781 |
| 27 | NEK1 | 1.26357464 |
| 28 | TRIM28 | 1.18576054 |
| 29 | BRSK2 | 1.15672541 |
| 30 | MAPK13 | 1.14730478 |
| 31 | SGK2 | 1.10294636 |
| 32 | NTRK3 | 1.07637677 |
| 33 | FRK | 1.04828016 |
| 34 | CAMK1G | 1.00552985 |
| 35 | GRK1 | 0.97492259 |
| 36 | ERBB3 | 0.97111735 |
| 37 | GSK3A | 0.96472061 |
| 38 | NLK | 0.94238773 |
| 39 | PRKAA2 | 0.94040496 |
| 40 | TGFBR1 | 0.93825753 |
| 41 | PRKG2 | 0.91873274 |
| 42 | DAPK2 | 0.91622548 |
| 43 | CAMK1D | 0.90139811 |
| 44 | NEK6 | 0.88363910 |
| 45 | CAMKK2 | 0.86903759 |
| 46 | EPHA3 | 0.86099183 |
| 47 | LIMK1 | 0.84806658 |
| 48 | PIK3CA | 0.83592271 |
| 49 | PTK2 | 0.83325845 |
| 50 | FLT3 | 0.81675899 |
| 51 | PAK4 | 0.76884701 |
| 52 | LMTK2 | 0.75919184 |
| 53 | DMPK | 0.75671023 |
| 54 | MYLK | 0.74177972 |
| 55 | PIK3CG | 0.73630128 |
| 56 | PDK4 | 0.73522904 |
| 57 | PDK3 | 0.73522904 |
| 58 | PNCK | 0.73335604 |
| 59 | MKNK2 | 0.72422408 |
| 60 | EPHB2 | 0.72108330 |
| 61 | MAPKAPK3 | 0.71205889 |
| 62 | MST1R | 0.70370384 |
| 63 | MAP3K4 | 0.70274337 |
| 64 | SGK1 | 0.69857280 |
| 65 | SGK3 | 0.69306598 |
| 66 | PRKCG | 0.68075910 |
| 67 | RIPK1 | 0.67661005 |
| 68 | MAP3K3 | 0.67539174 |
| 69 | MAP3K14 | 0.67427822 |
| 70 | PTK6 | 0.67145693 |
| 71 | ACVR1B | 0.65123216 |
| 72 | PRKD2 | 0.65103541 |
| 73 | PHKG1 | 0.64786655 |
| 74 | PHKG2 | 0.64786655 |
| 75 | IGF1R | 0.63518559 |
| 76 | MET | 0.63355887 |
| 77 | FER | 0.62381625 |
| 78 | NTRK1 | 0.59428287 |
| 79 | PRKAA1 | 0.59015551 |
| 80 | MUSK | 0.58482027 |
| 81 | MKNK1 | 0.57391507 |
| 82 | MELK | 0.57053330 |
| 83 | INSR | 0.55826605 |
| 84 | PRKCI | 0.53954815 |
| 85 | STK38 | 0.53330057 |
| 86 | ROCK1 | 0.52204073 |
| 87 | PAK3 | 0.51790908 |
| 88 | FGFR2 | 0.50466482 |
| 89 | MAPK15 | 0.50398792 |
| 90 | TNIK | 0.50199721 |
| 91 | ERBB2 | 0.50167645 |
| 92 | BMPR1B | 0.49492651 |
| 93 | CAMK2A | 0.48849549 |
| 94 | MAPKAPK5 | 0.48760543 |
| 95 | PRKCH | 0.48179915 |
| 96 | MAPK7 | 0.47670342 |
| 97 | MAPK12 | 0.46821502 |
| 98 | ERBB4 | 0.46435215 |
| 99 | PLK2 | 0.45495388 |
| 100 | BCKDK | 0.45172281 |
| 101 | DYRK2 | 0.44790949 |
| 102 | GRK7 | 0.43974097 |
| 103 | TXK | 0.43803678 |
| 104 | IRAK1 | 0.42898748 |
| 105 | PKN1 | 0.42349569 |
| 106 | GRK5 | 0.42031954 |
| 107 | CASK | 0.41788150 |
| 108 | CSNK1G2 | 0.40716523 |
| 109 | ABL1 | 0.40612185 |
| 110 | CSNK1A1L | 0.40212658 |
| 111 | EIF2AK3 | 0.40035544 |
| 112 | BCR | 0.39845924 |
| 113 | PBK | 0.39828953 |
| 114 | PAK2 | 0.39639459 |
| 115 | PRKCQ | 0.39623567 |
| 116 | PRKACA | 0.39348122 |
| 117 | MARK1 | 0.39234377 |
| 118 | PDGFRA | 0.38294195 |
| 119 | YES1 | 0.37354263 |
| 120 | PRKCA | 0.37251609 |
| 121 | NTRK2 | 0.36905399 |
| 122 | TEC | 0.36758245 |
| 123 | ABL2 | 0.36664599 |
| 124 | LRRK2 | 0.36015797 |
| 125 | TRPM7 | 0.35936501 |
| 126 | FGR | 0.35754519 |
| 127 | CDK6 | 0.35643930 |
| 128 | PRKG1 | 0.33089324 |
| 129 | LATS1 | 0.32515840 |
| 130 | CSNK1G1 | 0.32405345 |
| 131 | SIK1 | 0.31055987 |
| 132 | AKT2 | 0.30060789 |
| 133 | MAP2K2 | 0.28561751 |
| 134 | PRKD1 | 0.27284414 |
| 135 | SRC | 0.26923414 |
| 136 | ITK | 0.26732943 |
| 137 | DYRK1B | 0.26419638 |
| 138 | CSK | 0.26307370 |
| 139 | MAP3K6 | 0.24851758 |
| 140 | PRKCE | 0.23909511 |
| 141 | IRAK2 | 0.22783729 |
| 142 | MAP2K1 | 0.21745849 |
| 143 | EIF2AK2 | 0.21609978 |
| 144 | MARK2 | 0.20973039 |
| 145 | MAP3K7 | 0.20177989 |
| 146 | STK3 | 0.19602238 |
| 147 | EPHA4 | 0.19042471 |
| 148 | BMX | 0.18920915 |
| 149 | PDGFRB | 0.18885595 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 3.49424873 |
| 2 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.45579001 |
| 3 | Caffeine metabolism_Homo sapiens_hsa00232 | 3.38300892 |
| 4 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 3.30049327 |
| 5 | Butanoate metabolism_Homo sapiens_hsa00650 | 3.20346189 |
| 6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.88510740 |
| 7 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.87939749 |
| 8 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.77366096 |
| 9 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.75195136 |
| 10 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.69475922 |
| 11 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.68912315 |
| 12 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.57780953 |
| 13 | Protein digestion and absorption_Homo sapiens_hsa04974 | 2.52717166 |
| 14 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.47955038 |
| 15 | Bile secretion_Homo sapiens_hsa04976 | 2.46192727 |
| 16 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.42489279 |
| 17 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.34356115 |
| 18 | Peroxisome_Homo sapiens_hsa04146 | 2.30732137 |
| 19 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.13269683 |
| 20 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.05945941 |
| 21 | Lysine degradation_Homo sapiens_hsa00310 | 2.00204976 |
| 22 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.93927390 |
| 23 | Phototransduction_Homo sapiens_hsa04744 | 1.87209003 |
| 24 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.86364001 |
| 25 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.79174297 |
| 26 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.75403760 |
| 27 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.69364383 |
| 28 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.65184981 |
| 29 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.63343888 |
| 30 | Mineral absorption_Homo sapiens_hsa04978 | 1.62804059 |
| 31 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.60632718 |
| 32 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.54181344 |
| 33 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.53492075 |
| 34 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.53261372 |
| 35 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.50304166 |
| 36 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.49387275 |
| 37 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.47612624 |
| 38 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.46370192 |
| 39 | Adherens junction_Homo sapiens_hsa04520 | 1.41541804 |
| 40 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.40809642 |
| 41 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.40588096 |
| 42 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.38698668 |
| 43 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.37774043 |
| 44 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.37183136 |
| 45 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.32718857 |
| 46 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.28295359 |
| 47 | Protein export_Homo sapiens_hsa03060 | 1.22044011 |
| 48 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.15677177 |
| 49 | Focal adhesion_Homo sapiens_hsa04510 | 1.11630974 |
| 50 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.10927714 |
| 51 | Basal transcription factors_Homo sapiens_hsa03022 | 1.00743024 |
| 52 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.00247425 |
| 53 | Nicotine addiction_Homo sapiens_hsa05033 | 0.99276999 |
| 54 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.99126304 |
| 55 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.98569128 |
| 56 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.98081808 |
| 57 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.96115963 |
| 58 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.95242403 |
| 59 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.94124366 |
| 60 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.93259973 |
| 61 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.91738852 |
| 62 | Circadian rhythm_Homo sapiens_hsa04710 | 0.88504940 |
| 63 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.81419762 |
| 64 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.81200799 |
| 65 | Other glycan degradation_Homo sapiens_hsa00511 | 0.79959433 |
| 66 | Taste transduction_Homo sapiens_hsa04742 | 0.79278140 |
| 67 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.75766278 |
| 68 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.75756921 |
| 69 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.75350730 |
| 70 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.74520550 |
| 71 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.73402669 |
| 72 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.72731952 |
| 73 | Carbon metabolism_Homo sapiens_hsa01200 | 0.72193034 |
| 74 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.71940404 |
| 75 | Homologous recombination_Homo sapiens_hsa03440 | 0.69543653 |
| 76 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.64914088 |
| 77 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.64247264 |
| 78 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.63791257 |
| 79 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.63776060 |
| 80 | Prostate cancer_Homo sapiens_hsa05215 | 0.63758582 |
| 81 | Histidine metabolism_Homo sapiens_hsa00340 | 0.63705352 |
| 82 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.62355470 |
| 83 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.61810728 |
| 84 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.61437095 |
| 85 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.60526088 |
| 86 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.60445576 |
| 87 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.57562391 |
| 88 | Tight junction_Homo sapiens_hsa04530 | 0.56882684 |
| 89 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.56743669 |
| 90 | Morphine addiction_Homo sapiens_hsa05032 | 0.56588960 |
| 91 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.54653192 |
| 92 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.52595306 |
| 93 | RNA polymerase_Homo sapiens_hsa03020 | 0.52395498 |
| 94 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.49777017 |
| 95 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.48165645 |
| 96 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.47322788 |
| 97 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.47241656 |
| 98 | Olfactory transduction_Homo sapiens_hsa04740 | 0.45948439 |
| 99 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.45895319 |
| 100 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.44714100 |
| 101 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.44500305 |
| 102 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.43506006 |
| 103 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.42376380 |
| 104 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.41864607 |
| 105 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.41366675 |
| 106 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.41137465 |
| 107 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.40244185 |
| 108 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.40242985 |
| 109 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.40134317 |
| 110 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.39551779 |
| 111 | Insulin secretion_Homo sapiens_hsa04911 | 0.38656112 |
| 112 | Sulfur relay system_Homo sapiens_hsa04122 | 0.38410154 |
| 113 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.38034450 |
| 114 | Axon guidance_Homo sapiens_hsa04360 | 0.37878851 |
| 115 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.37761483 |
| 116 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.36207580 |
| 117 | Salivary secretion_Homo sapiens_hsa04970 | 0.36148144 |
| 118 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.35965089 |
| 119 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.35485021 |
| 120 | Parkinsons disease_Homo sapiens_hsa05012 | 0.35031140 |
| 121 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.34923046 |
| 122 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.34445767 |
| 123 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.34161235 |
| 124 | ABC transporters_Homo sapiens_hsa02010 | 0.31724794 |
| 125 | GABAergic synapse_Homo sapiens_hsa04727 | 0.31300022 |
| 126 | Melanoma_Homo sapiens_hsa05218 | 0.31066490 |
| 127 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.31037363 |
| 128 | Insulin resistance_Homo sapiens_hsa04931 | 0.30209239 |
| 129 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.29958634 |
| 130 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.29198105 |
| 131 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.28198925 |
| 132 | Retinol metabolism_Homo sapiens_hsa00830 | 0.27340464 |
| 133 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.26236125 |
| 134 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.24607266 |
| 135 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.24484698 |
| 136 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.22620477 |
| 137 | Metabolic pathways_Homo sapiens_hsa01100 | 0.21728690 |
| 138 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.21727996 |
| 139 | Renin secretion_Homo sapiens_hsa04924 | 0.21057397 |
| 140 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.20632082 |
| 141 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.20384839 |
| 142 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.18521595 |
| 143 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.17850763 |
| 144 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.16127175 |
| 145 | Pathways in cancer_Homo sapiens_hsa05200 | 0.15264923 |

